Scaling remains a key bottleneck for many food biotech companies. While technologies mature in the lab, moving to commercial scale is often constrained by access to infrastructure, high capital requirements, and limited availability of suitable facilities. This interactive session focuses on how entrepreneurs navigate that phase, and the role that national initiatives could play to facilitate growth. Scaling involves […]
